Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial Meeting Abstract
| Authors: | Feils, A.; Erbe, A.; Birstler, J.; Kim, K.; Hoch, U.; Currie, S.; Nguyen, T.; Yu, D.; Siefker-Radtke, A.; Tannir, N.; Hellmann, M.; Tolaney, S.; Diab, A.; Sondel, P. |
| Abstract Title: | Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial |
| Meeting Title: | 36th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2021) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 9 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Nov 10-14 |
| Meeting Location: | Washington, DC |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2021-11-01 |
| Start Page: | A67 |
| Language: | English |
| ACCESSION: | WOS:000774877500060 |
| DOI: | 10.1136/jitc-2021-SITC2021.059 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 59 -- Meeting was also presented virtually -- Source: Wos |
